The global cell culture media market is projected to reach $9.1 billion by 2028, at a CAGR of 12.3% during 2023-2028. The growth of cell culture media market is driven by expanding biopharmaceutical industry, increasing demand for monoclonal bodies and vaccine production, and growing expenditure in research and development activities in the life science sector.
Some of the Key Questions answered in this exclusive report are:
Q.1 What are some of the most promising, high-growth opportunities for the cell culture media market by product (serum-free media, classical media, , and others), type (liquid media and semi-solid & solid media), application (biopharmaceutical production, diagnostics, drug screening and development, tissue engineering and regenerative medicine, and others), end use industry (pharmaceutical and biotechnology companies, hospitals and diagnostic laboratories, research and academic institutes, and others), and region?
Q.2 Which segments will grow at a faster pace and why?
Q.3 What are the business risks and threats to the cell culture media market?
Q.4 What are some changing demands of customers in the cell culture media market?
Q.5 What are the new developments in the cell culture media market? Which companies are leading these developments?
Q.6 What strategic initiatives are being implemented by key players for business growth?
Q.7 What are some of the competitive products and processes in this cell culture media area and how big of a threat do they pose for loss of market share via product substitution?
Q.8 What M&A activity has occurred in the last 5 years in this cell culture media market?
Market Segmentation:
Based on product, the cell culture media market is segmented into serum-free media, classical media, and others. The serum free segment accounted for the largest share of the market in 2023 and is expected to register the highest CAGR during the forecast period, due to its increasing usage in the treatment for molecular genetics, cancer research and plant research as it ensures improved productivity and reduced risk relate to contamination by serum-borne adventitious agents in the culture.
North America will remain the largest region due to the growing number of cancer patients and supportive funds for R&D activity of cell culture in the region.
Key Players in the cell culture media market are Thermo Fisher, Merck, CYTIVA, Sartorius, FUJIFILM Irvine Scientific.
Request Sample Pages by clicking on https://www.lucintel.com/cell-culture-media-market.aspx
The report helps stakeholders understand the pulse of the market and provides them with information on key drivers, restraints, challenges, and opportunities for market growth. It would also help to understand the competitors better and gain more insights to improve their position in the business.
To read more about this market please click on https://www.lucintel.com/cell-culture-media-market.aspx
About Lucintel
Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. 972.636.5056
Roy Almaguer Lucintel Dallas, Texas, USA Email: roy.almaguer@lucintel.com Tel. 972.636.5056
Tags:
Reportedtimes, Extended Distribution, iCN Internal Distribution, Research Newswire, English